Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles-Reference-Cited by-同舟云学术

Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles

Published:2013-02-08 Issue:2 Volume:8 Page:e55681
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gracia-Aznarez Francisco Javier,Fernandez Victoria,Pita Guillermo,Peterlongo Paolo,Dominguez Orlando,de la Hoya Miguel,Duran Mercedes,Osorio Ana,Moreno Leticia,Gonzalez-Neira Anna,Rosa-Rosa Juan Manuel,Sinilnikova Olga,Mazoyer Sylvie,Hopper John,Lazaro Conchi,Southey Melissa,Odefrey Fabrice,Manoukian Siranoush,Catucci Irene,Caldes Trinidad,Lynch Henry T.,Hilbers Florentine S. M.,van Asperen Christi J.,Vasen Hans F. A.,Goldgar David,Radice Paolo,Devilee Peter,Benitez Javier

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1;Y Miki;Science,1994

2. Identification of the breast cancer susceptibility gene BRCA2;R Wooster;Nature,1995

3. Screening for germ line TP53 mutations in breast cancer patients;AL Borresen;Cancer Res,1992

4. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis;ED Lynch;Am J Hum Genet,1997

5. Very high risk of cancer in familial Peutz-Jeghers syndrome;FM Giardiello;Gastroenterology,2000

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population‐specific validation and comparison of the performance of 77‐ and 313‐variant polygenic risk scores for breast cancer risk prediction;Cancer;2024-05-08

2. Uncovering hidden genetic risk factors for breast and ovarian cancers in BRCA-negative women: a machine learning approach in the Saudi population;PeerJ Computer Science;2024-04-19

3. A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients;NAR Genomics and Bioinformatics;2024-04-04

4. Pathogenic and likely pathogenic germline variation in patients with myeloid malignancies and their unrelated HLA-matched hematopoietic stem cell donors;Journal of Translational Genetics and Genomics;2024-01-25

5. Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population;International Journal of Molecular Sciences;2023-02-17